US FDA grants IDE approval for pivotal clinical trial of MicroStent
Ngày 10/07/2019 07:11 | Lượt xem: 1379

Micro Medical Solutions has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA). IDE approval allows the company to initiate a US pivotal clinical trial to evaluate MicroStent’s safety and efficacy. A press release reports that MicroStentis a vascular stent specifically designed to achieve and maintain vessel patency and improve blood flow in order to reduce below-the-knee amputations for patients with critical limb ischaemia resulting from peripheral arterial disease.

Last year, Micro Medical Solutions completed a three-centre, 15-patient feasibility study of MicroStent in which MicroStent met all primary endpoints for both safety and efficacy. The study demonstrated in the device-related per protocol population that 90.9% of patients had primary patency at six months’ post-index procedure, which is a composite of 90.9% of patients with freedom from occlusion, while 100% were free from a clinically driven target lesion revascularisation. The study also showed 100% of patients had freedom from the primary safety endpoint at six months’ post-index procedure, which is a composite of 100% of patients with freedom from death and 100% freedom from major adverse limb events in the same population.

The FDA has granted IDE status based on these outcomes. Micro Medical Solutions will immediately initiate the process to begin enrolment in the clinical trial, called the STAND study (A clinical evaluation of the MicroStent peripheral vascular stent in patients with arterial disease below the knee).

Robert E Beasley (Mount Sinai Medical Center, Miami Beach, USA), the lead investigator, comments: “Because critical limb ischaemia represents the most severe clinical manifestation of peripheral arterial disease, we are excited to have a device that offers physicians multiple access points, as well as a trial that allows for reintervention to effectively treat and lessen the impending limb and tissue loss.”

Jihad A Mustapha (Advanced Cardiac & Vascular Centers for Amputation Prevention in Grand Rapids, USA), states: “For patients with peripheral arterial disease, the risk of amputation is high, particularly if they have critical limb ischaemia. Amputees face decreased quality of life, as well as amputation-associated mortality. I look forward to the clinical trial for MicroStent because we need new solutions to help save critical limb ischaemia patients from amputation.”

Source VascularNews

Duc Tin Clinic

Print Chia sẽ qua facebook bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua google bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua twitter bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua MySpace bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua LinkedIn bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua stumbleupon bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua icio bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua digg bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua yahoo bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua yahoo bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua yahoo bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent Chia sẽ qua yahoo bài: US FDA grants IDE approval for pivotal clinical trial of MicroStent

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP